Topic: Vaccine
Not Oxford lab, not US company, Covid solution will come from India, China pharma industry
Fast and mass pharma production in India and China is crucial if the coronavirus pandemic is to be brought under control.
Are people who have had Covid-19 immune? Perhaps not
What needs to happen now is a series of studies to determine whether the presence of antibodies is associated with protection against re-infection with SARS-CoV-2.
Covid vaccine makers may need to infect subjects to get results
As the infection rate changes, companies running drug trials will face a new problem — not enough test subjects in their regions.
Indian vaccine ventures with global partners could move to human trials soon: VijayRaghavan
At least 14 vaccine candidates being developed solely by Indian players, but none ready for human trials stage yet, Principal Scientific Adviser K. VijayRaghavan says.
Why vaccines should not be immune to market forces
Market prices for vaccines could ensure additional production, help differentiate between vaccines, and even allocation of resources.
Green shoots emerge in world economy as virus lockdowns ease
Indicators such as electricity demand and traffic congestions point to a modest 'lift of lows', as economic recovery remains uneven in the absence of a vaccine.
There will be more than one coronavirus vaccine, and that will be a merry situation
With over 70 vaccine candidates, the end of the Covid crisis will likely be multiple vaccines, some more traditional and others based on emerging technologies.
US pharma giant Merck hopes to beat coronavirus with a pill and two vaccines
Merck bought rights to develop a promising antiviral and will work with partners to advance candidate vaccines based on the technology behind Ebola and measles immunizations.
Xi Jinping is seeking to beat Trump in the race for a coronavirus vaccine
China has promised to share any successful vaccine globally, and would wield immense geopolitical clout if it produces one of the world’s first working shots.
Chinese vaccine shows promise in early human trial, generates immune response against Covid
The vaccine developed by CanSino Biologics is the first candidate to be tested in human trials.
Globalisation of revenge
Nobody looks more ridiculous in the whole Iraq situation than the Europeans. A bit of their hypocrisy was on show in New Delhi.
IndiGo to trim fleet size over 2 years as Covid pandemic rages on
IndiGo CEO Ronojoy Dutta said the airline hasn’t engaged in any 'major renegotiation' with Airbus SE on new deliveries, but it will keep returning as many as 40 older planes a year.
Defence
First phase of Quad members’ Malabar exercise from 3-6 November in Bay of Bengal
Last week, India had announced Australia will take part in the exercise along with US and Japan, making it a drill by all 4 member nations of the Quad or Quadrilateral coalition.
Trump or Biden? Doesn’t matter to India-US ties as they’re in a full, strategic embrace
Pompeo & Esper’s visit to India for the 2+2 talks is proof that old hypocrisies are history, and supreme national interest has again driven a strategic choice.